Breaking News

These leaders are forging ahead on health equity; why health insurance tech companies are still struggling to turn profits

 

 

Daily Recap

The nation hasn't made much progress on health equity. These leaders forged ahead anyway

By Usha Lee McFarling

Hannah Yoon for STAT

Several programs around the country reveal the struggle to advance health equity may be at an important inflection point.

Read More

STAT+: Health insurance tech companies, struggling to turn profits, bet on software to turn business around

By Mohana Ravindranath

Oscar Health

Oscar and Clover want to overhaul the health insurance industry with the help of tech. But they've yet to prove they can make money.

Read More

STAT+: With new trial data coming, Intellia CEO talks up the future of in vivo gene editing

By Megan Molteni

STAT

The data released Monday should answer a number of questions, including how big a reduction in TTR is achievable with higher doses.

Read More

STAT+: Judge bars Shkreli from running another public company, fines him $1.4 million

By Ed Silverman

Drew Angerer/Getty Images

A judge granted the SEC's request to permanently bar Martin Shkreli from serving as an officer or director of any publicly traded company.

Read More

Justice Department sues UnitedHealth over nearly $8 billion deal to acquire tech company

By Tom Murphy — Associated Press

Jim Mone/AP

Federal regulators are suing to block UnitedHealth Group's purchase of the technology company Change Healthcare.

Read More

STAT+: Unraveling of Amicus spinout spells more trouble for gene therapy field

By Adam Feuerstein

Adobe

The abrupt dissolution of a blank-check merger points to more trouble for the already deflated gene therapy field.

Read More

Opinion: To restore public trust, the CDC must stop legitimizing the expulsion of asylum seekers

By Juliana Morris and Stephanie Sun and Rashmi Jasrasaria

Apu Gomes/Getty Images

The CDC continues to peddle the necessity of turning away asylum seekers even though there is no public health rationale for doing that.

Read More

Listen: Medical racism, new Covid vaccines, & the resilience of Regeneron

By Damian Garde and Meg Tirrell and Adam Feuerstein

We discuss the latest news in Covid-19 vaccines, including data from Sanofi and GSK, the future of Novavax, and what comes next for Moderna.

Read More

Thursday, February 24, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments